Patent · US Active

Pyrazolylaminopyridine derivatives useful as kinase inhibitors

US8835465B2 · kind B2 · utility

0Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 29, 2012
Grant dateSep 16, 2014
Priority date
Expiry dateNov 29, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention relates to novel compounds having the formula (I):and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.